Selected Publications
ZMB Publications
Selected Publications
The list provides selected publications of the ZMB from 2004 to 2021, published in the journals listed below.
You can narrow the list down by year and author. If an error accured or no data was found, please reload or reset the page.
(View all ZMB publications via the interface of the university bibliography).
Journals
- ACS Nano
- Acta Neuropathologica
- Advanced Drug Delivery Reviews
- All Nature Journals
- American Journal of Human Genetics
- Angewandte Chemie International Edition
- Annals of Oncology
- Annual Review of Biochemistry
- Annual Review of Genetics
- Annual Review of Microbiology
- Biomaterials
- Biotechnology Advances
- Blood
- Brain
- Cancer Cell
- Cancer Discovery
- Cancer Research
- Cell
- Clinical Cancer Research
- Cell Reports
- Chemical Reviews
- Chemical Society Reviews
- Circulation
- Circulation Research
- Current Biology
- eLife
- EMBO Molecular Medicine
- EMBO Reports
- Endocrine Reviews
- European Heart Journal
- FEMS Microbiology Reviews
- Gastroenterology
- Genes and Development
- Gut
- Hepatology
- Immunity
- Immunological Reviews
- JAMA: Journal of the American Medical Association
- JAMA Oncology
- JAMA Neurology
- Journal of Hepatology
- Journal of the American Chemical Society
- Journal of the American Medical Association
- Journal of Clinical Oncology
- Journal of Hepatology
- Lancet
- Leukemia
- Molecular Cell
- Molecular Psychiatry
- Natural Product Research
- Nature
- Nature Biotechnology
- Nature Cancer
- Nature Cell Biology
- Nature Chemical Biology
- Nature Communications
- Nature Genetics
- Nature Medicine
- Nature Methods
- Nature Nanotechnology
- Nature Reviews Clinical Oncology
- Nature Reviews Molecular Cell Biology
- Nature Reviews Neurology
- Nature Structural & Molecular Biology
- Neuro-Oncology
- Nucleic Acids Research
- Proceedings of the National Academy of Sciences of the United States of America Science
- Science
- Science Advances
- Small
- The British Journal of Cancer
- The EMBO Journal
- The Journal of Cell Biology
- The Journal of Clinical Investigation (JCI)
- The Lancet
- The Lancet Diabetes and Endocrinology
- The Lancet Gastroenterology & Hepatology
- The Lancet Infectious Diseases
- The Lancet Neurology
- The Lancet Oncology
- The New England Journal of Medicine
- Trends in Neurosciences
- Trends in Pharmacological Sciences
There were 1182 publications found
-
Condensins regulate resection-dependent DNA double-strand break repair pathways in replicated chromatinIn: Nucleic Acids Research, Vol. 54, 2026, Nr. 4, gkag076DOI (Open Access)
-
Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expression in pancreatic ductal adenocarcinomaIn: Nature Communications, Vol. 17, 2026, Nr. 1, 1476DOI (Open Access)
-
CUL4A-DDB1-DCAF10 is an N-recognin for N-terminally acetylated Src kinasesIn: Nature Communications, Vol. 17, 2026, Nr. 1, 132DOI (Open Access)
-
M18BP1 valency and a distributed interaction footprint determine epigenetic centromere specification in humansIn: The EMBO Journal, 2026, in pressDOI (Open Access)
-
Molecular requirements for PLK1 activation by T-loop phosphorylationIn: The EMBO Journal, Vol. 45, 2026, Nr. 5, pp. 1496 – 1536DOI (Open Access)
-
Activated ATF6α is a hepatic tumour driver restricting immunosurveillanceIn: Nature, 2026, in pressDOI (Open Access)
-
Covalent modification of a glutamic acid inspired by HaloTag technologyIn: Nature Communications, Vol. 17, 2026, Nr. 1, 1257DOI (Open Access)
-
Vibostolimab coformulated with pembrolizumab versus pembrolizumab alone as adjuvant therapy for high-risk stage IIB–IV melanoma (KEYVIBE-010) : A randomised, double-blind, phase 3 studyIn: The Lancet Oncology, Vol. 27, 2026, Nr. 3, pp. 327 – 339DOI (Open Access)
-
Deep Learning-Derived Sarcopenia Marker Predicts Benefit from Anti-EGFR Therapy in Patients with RAS Wild-type Metastatic Colorectal CancerIn: Clinical Cancer Research, Vol. 32, 2026, Nr. 5, pp. 938 – 946DOI (Open Access)
-
PET/CT-guided management of immune checkpoint blockade and multi-modal profiling following treatment in long-term responders with metastatic lung cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM)In: Annals of Oncology, Vol. 37, 2026, Nr. 5, pp. 686 – 700DOI (Open Access)
-
Atomic-Scale Understanding of Selectivity Control in Nitrate Reduction on Cu(100) Under Acidic and Alkaline ConditionsIn: Angewandte Chemie International Edition, 2026, in pressDOI (Open Access)
-
The accessory adapters FAF1, FAF2, and UBXN7 accelerate proteasomal degradation by increasing prior p97-mediated substrate unfoldingIn: Science Advances, Vol. 12, 2026, Nr. 10, eaea7381DOI, Online Full Text (Open Access)
-
Adjuvant Imatinib or Observation in Patients with Gastrointestinal Stromal Tumors with KIT Exon 9 MutationsIn: JAMA Oncology, Vol. 12, 2026, Nr. 4, pp. 407 – 412
-
Sulfated glycosaminoglycans inhibit LCMV entry and modulate antiviral immunity and pathologyIn: EMBO Molecular Medicine, Vol. 18, 2026, Nr. 4, pp. 1235 – 1264DOI (Open Access)
-
Probing a Reactive Alkyne Center Aligned via a Triphenylmethane Tripod on Au(111) for Electric Field-Induced Chemistry by STM and TERSIn: Small, Vol. 22, 2026, Nr. 7, e09467DOI (Open Access)
-
Thyrotropin-releasing hormone neurons of different hypothalamic nuclei increase energy expenditureIn: Nature Communications, Vol. 17, 2026, Nr. 1, 3499DOI (Open Access)
-
Discovery of an Endonuclease G-inhibitory Ku80-peptide protecting against leukemogenic rearrangements at the MLL breakpoint clusterIn: Nature Communications, Vol. 17, 2026, Nr. 1, 3562DOI (Open Access)
-
Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumorIn: Nature Communications, Vol. 17, 2026, Nr. 1, 3397DOI (Open Access)
-
Exploratory Analysis of Biomarkers and Treatment Outcomes from the COLUMBUS Study in BRAF V600E/K–Mutant Advanced or Metastatic MelanomaIn: Clinical Cancer Research, Vol. 32, 2026, Nr. 7, pp. 1266 – 1276DOI (Open Access)
-
CCL3 is produced by aged neutrophils across cancers and promotes tumor growthIn: Cancer Cell, Vol. 44, 2026, Nr. 3, pp. 624 – 640.e12DOI (Open Access)
-
Ancient co-option of LTR retrotransposons as yeast centromeresIn: Nature, 2026, in pressDOI (Open Access)
-
Type I IFN-dependent FcγRIV signaling in murine monocytes promotes lethal anaphylaxis during viral infectionsIn: The Journal of Clinical Investigation (JCI), Vol. 136, 2026, Nr. 4, e192371DOI, Online Full Text (Open Access)
-
Interplay of SLC33A1-dependent and -independent Golgi sialic acid O-acetylation in CASD1 catalysisIn: Nature Communications, Vol. 17, 2026, Nr. 1, 3156DOI, Online Full Text (Open Access)
-
Molecular anatomy of PLK1 master docking motifsIn: Nature Communications, Vol. 17, 2026, Nr. 1, 4228DOI (Open Access)
-
Heart failure therapy in patients with advanced cancer receiving specialized palliative care (EMPATICC trial)In: European Heart Journal, Vol. 47, 2026, Nr. 9, pp. 1034 – 1046DOI (Open Access)
-
PDS5 proteins control genome architecture by limiting the lifetime of cohesin-NIPBL complexesIn: Molecular Cell, 2026, in pressDOI (Open Access)
-
Unifying Scaling Relations and Multiple Reaction Mechanisms for Screening Transition Metal-Doped Co3O4 for Oxygen Evolution ReactionIn: Angewandte Chemie International Edition, 2026, e24523 , in pressDOI (Open Access)
-
Combined transcatheter mitral and tricuspid edge-to-edge repair or tricuspid edge-to-edge repair alone in moderate mitral regurgitation : a propensity-matched analysisIn: European Heart Journal, 2026, in pressDOI (Open Access)
-
Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastomaIn: The Journal of Clinical Investigation (JCI), Vol. 136, 2026, Nr. 7, 189152DOI (Open Access)
-
Targeted degradation of USP7 in solid cancer cells reveals distinct effects of deubiquitinase degraders and inhibitorsIn: Nature Communications, Vol. 17, 2026, Nr. 1, 4331DOI (Open Access)
-
IO102-IO103 immune-modulatory cancer vaccine and pembrolizumab in melanomaIn: Annals of Oncology, 2026, in press
-
Reverse engineering of BNIP3 identifies a mitochondrial protective peptideIn: Nature Communications, Vol. 17, 2026, Nr. 1, 5359DOI (Open Access)
-
Genetic and functional analyses of CTBP2 in anorexia nervosa and body weight regulationIn: Molecular Psychiatry, Vol. 30, 2025, Nr. 5, pp. 1836 – 1846DOI (Open Access)
-
HBV shows different levels of adaptation to HLA class I-associated selection pressure correlating with markers of replicationIn: Journal of Hepatology, Vol. 82, 2025, Nr. 5, pp. 805 – 815DOI (Open Access)
-
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trialIn: Nature Medicine, Vol. 31, 2025, Nr. 1, pp. 152 – 164DOI (Open Access)
-
Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancerIn: Nature Communications, Vol. 16, 2025, Nr. 1, 335DOI (Open Access)
-
High Glucose Contribution to the TCA Cycle Is a Feature of Aggressive Non-Small Cell Lung Cancer in PatientsIn: Cancer Discovery, Vol. 15, 2025, Nr. 4, pp. 702 – 716DOI (Open Access)
-
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced MelanomaIn: The New England Journal of Medicine, Vol. 392, 2025, Nr. 1, pp. 11 – 22DOI, Online Full Text (Open Access)
-
Nitro-oleic acid enhances mitochondrial metabolism and ameliorates heart failure with preserved ejection fraction in miceIn: Nature Communications, Vol. 16, 2025, Nr. 1, 3933DOI (Open Access)
-
Discordance, accuracy and reproducibility study of pathologists’ diagnosis of melanoma and melanocytic tumorsIn: Nature Communications, Vol. 16, 2025, Nr. 1, 789DOI (Open Access)
-
Immunothrombolytic monocyte-neutrophil axes dominate the single-cell landscape of human thrombosis and correlate with thrombus resolutionIn: Immunity, Vol. 58, 2025, Nr. 5, pp. 1343 – 1358.e13DOI (Open Access)
-
PLK1 blockade enhances the anti-tumor effect of MAPK inhibition in pancreatic ductal adenocarcinomaIn: Cell Reports, Vol. 44, 2025, Nr. 4, 115541DOI (Open Access)
-
Molecular determinants of sotorasib clinical efficacy in KRASG12C-mutated non-small-cell lung cancerIn: Nature Medicine, Vol. 31, 2025, Nr. 8, pp. 2755 – 2767DOI (Open Access)
-
Oxygen evolution reaction on IrO₂(110) is governed by Walden-type mechanismsIn: Nature Communications, Vol. 16, 2025, Nr. 1, 6137DOI (Open Access)
-
The human cytomegalovirus-encoded pUS28 antagonizes CD4+ T cell recognition by targeting CIITAIn: eLife, Vol. 14, 2025, e96414DOI, Online Full Text (Open Access)
-
Gemtuzumab ozogamicin in first-line treatment of CBF-AML : Insights from a retrospective multi-center analysisIn: Leukemia, Vol. 39, 2025, Nr. 9, pp. 2174 – 2180DOI (Open Access)
-
Muscle growth by sarcomere divisionsIn: Science Advances, Vol. 11, 2025, Nr. 28, eadw9445DOI (Open Access)
-
Renaissance of Chlorine Evolution Reaction : Emerging Theory and Catalytic MaterialsIn: Angewandte Chemie International Edition, Vol. 64, 2025, Nr. 1, e202417293DOI (Open Access)
-
Multistate kinetics of the syringe-like injection mechanism of Tc toxinsIn: Science Advances, Vol. 11, 2025, Nr. 1, eadr2019DOI (Open Access)